nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2025, 08, v.27 1129-1132
神经胶质细胞介导的神经炎症与阿尔茨海默病发病机制的研究进展
基金项目(Foundation): 内蒙古自治区自然科学基金项目(2024LHMS08004); 内蒙古医学科学院公立医院科研联合基金科技项目(2023GLLH0191;2024GLLH0565)
邮箱(Email): guoxia0424@163.com;
DOI:
发布时间: 2025-08-07
出版时间: 2025-08-07
移动端阅读
摘要:

<正>阿尔茨海默病(Alzheimer's disease,AD)是好发于中老年患者的一种神经退行性疾病,以进行性认知功能障碍为主要特征,目前普遍的共识是_β淀粉样蛋白(β-amyloid peptide,Aβ)沉积后触发神经元纤维缠结、突触丢失和细胞死亡导致AD的发生发展。近年来,越来越多的证据表明神经炎症过程在AD的进展中发挥重要作用,而活化的小胶质细胞和星形胶质细胞与神经炎症密切相关[1]。一方面,神经炎症可以引发神经胶质细胞的吞噬功能激活免疫应答以消除潜在的病原体并去除其碎片;另一方面,神经炎症通过促进Aβ沉积的细胞毒性物质而产生不良作用,加剧AD患者神经元的损害。本综述就近年来国内外有关神经胶质细胞介导的神经炎症在AD发病机制中作用的研究进展作一概述,以期为AD发病机制的研究及治疗提供新策略。

Abstract:

KeyWords:
参考文献

[1] Gotoh M,Miyamoto Y,Ikeshima-kataoka H.Astrocytic neuroimmunological roles interacting with microglial cells in neurodegenerative diseases[J].Int J Mol Sci,2023,24(2):1599.DOI:10.3390/ijms24021599.

[2] Yong VW.Microglia in multiple sclerosis:protectors turn destroyers[J].Neuron,2022,110(21):3534-3548.DOI:10.1016/j.neuron.2022.06.023.

[3] Kong C,Yang EJ,Shin J,et al.Enhanced delivery of a low dose of aducanumab via FUS in 5×FAD mice,an AD model[J].Transl Neurodegener,2022,11(1):57.DOI:10.1186/s40035-022-00333-x.

[4] Flury A,Aljayousi L,Park HJ,et al.A neurodegenerative cellular stress response linked to dark microglia and toxic lipid secretion[J].Neuron,2025,113(4):554-571.e14.DOI:10.1016/j.neuron.2024.11.018.

[5] McAlpine CS,Park J,Griciuc A,et al.Astrocytic interleukin-3 programs microglia and limits Alzheimer's disease[J].Nature,2021,595(7869):701-706.DOI:10.1038/s41586-021-03734-6.

[6] Edison P.Astroglial activation:current concepts and future directions[J].Alzheimers Dement,2024,20(4):3034-3053.DOI:10.1002/alz.13678.

[7] Endo F,Kasai A,Soto JS,et al.Molecular basis of astrocyte diversity and morphology across the CNS in health and disease[J].Science,2022,378(6619):eadc9020.DOI:10.1126/science.adc9020.

[8] Depp C,Sun T,Sawmita AO,et al.Myelin dysfunction drives amyloid-β deposition in models of Alzheimer's disease[J].Nature,2023,618(7964):349-357.DOI:10.1038/s41586-023-06120-6.

[9] Kaya T,Mattugini N,Liu L,et al.CD8(+) T cells induce interferon-responsive oligodendrocytes and microglia in white matter aging[J].Nat Neurosci,2022,25(11):1446-1457.DOI:10.1038/s41593-022-01183-6.

[10] Msthys H,Peng Z,Boix CA,et al.Single-cell atlas reveals correlates of high cognitive function,dementia,and resilience to Alzheimer's disease pathology[J].Cell,2023,186(20):4365-4385.e27.DOI:10.1016/j.cell.2023.08.039.

[11] Twarowski B,Herbet M.Inflammatory processes in Alzheimer's disease-pathomechanism,diagnosis and treatment:a review[J].Int J Mol Sci,2023,24(7):6518.DOI:10.3390/ijms24076518.

[12] Grubman A,Choo XY,Chew G,et al.Transcriptional signature in microglia associated with Aβ plaque phagocytosis[J].Nat Commun,2021,12(1):3015.DOI:10.1038/s41467-021-23111-1.

[13] Zhang Y,Chu JMT,Wong GTC.Cerebral glutamate regulation and receptor changes in perioperative neuroinflammation and cognitive dysfunction[J].Biomolecules,2022,12(4):597.DOI:10.3390/biom12040597.

[14] Qiu Q,LI C,Zhao X,et al.Farnesylthiosalicylic acid through inhibition of galectin-3 improves neuroinflammation in Alzheimer disease via multiple pathways[J].CNS Neurosci Ther,2024,30(11):e70127.DOI:10.1111/cns.70127.

[15] Merighi S,Nigro M,Travagli A,et al.A(2A) Adenosine receptor:a possible therapeutic target for Alzheimer's disease by regulating NLRP3 inflammasome activity?[J].Int J Mol Sci,2022,23(9):5056.DOI:10.3390/ijms23095056.

[16] Liu J,Wang Z,Liang W,et al.Microglial TMEM119 binds to amyloid-β to promote its clearance in an Aβ-depositing mouse model of Alzheimer's disease[J].Immunity,2025,58(7):1830-1846.e7.DOI:10.1016/j.immuni.2025.04.018.

[17] Lubben N,Brynildsen JK,Webb CM,et al.LRRK2 kinase inhibition reverses G2019S mutation-dependent effects on tau pathology progression[J].Transl Neurodegener,2024,13(1):13.DOI:10.1186/s40035-024-00403-2.

[18] Fritze J,Muralidharan C,Stamp E,et al.Microglia undergo disease-associated transcriptional activation and CX3C motif chemokine receptor 1 expression regulates neurogenesis in the aged brain[J].Dev Neurobiol,2024,84(3):128-141.DOI:10.1002/dneu.22939.

[19] Chidambaram H,Das R,Chinnathambi S.Interaction of Tau with the chemokine receptor,CX3CR1 and its effect on microglial activation,migration and proliferation[J].Cell Biosci,2020,10:109.DOI:10.1186/s13578-020-00474-4.

[20] Tillmon H,Soteros BM,Shen L,et al.Complement and microglia activation mediate stress-induced synapse loss in layer 2/3 of the medial prefrontal cortex in male mice[J].Nat Commun,2024,15(1):9803.DOI:10.1038/s41467-024-54007-5.

[21] Sanford SAI,Mcewan WA.Type-I interferons in Alzheimer's disease and other tauopathies[J].Front Cell Neurosci,2022,16:949340.DOI:10.3389/fncel.2022.949340.

[22] Chai YL,Lee JH,Chong JR,et al.Inflammatory panel cytokines are elevated in the neocortex of late-stage Alzheimer's disease but not Lewy body dementias[J].J Neuroinflamm,2023,20(1):111.DOI:10.1186/s12974-023-02789-8.

[23] Dejanovic B,Wu T,Tsai MC,et al.Complement C1q-dependent excitatory and inhibitory synapse elimination by astrocytes and microglia in Alzheimer's disease mouse models[J].Nat Aging,2022,2(9):837-850.DOI:10.1038/s43587-022-00281-1.

[24] Rudkowski K,Waszczuk K,Tyburski E,et al.Complement activation products in patients with chronic schizophrenia[J].J Clin Med,2023,12(4):1577.DOI:10.3390/jcm12041577.

[25] Merighi S,Nigro M,Travagli A,et al.Microglia and Alzheimer's disease[J].Mech Ageing Dev,2022,23(21):12990.DOI:10.3390/ijms232112990.

[26] 栗文静,白艳杰,王岩,等.M2小胶质细胞外囊泡在缺血性脑卒中作用中的研究进展[J].中华老年心脑血管病杂志,2024,26(6):725-728.DOI:10.3969/j.issn.1009-0126.2024.06.029

[27] Paudel YN,Angelopoulou E,Piperi C,et al.Impact of HMGB1,RAGE,and TLR4 in Alzheimer's disease (AD):from risk factors to therapeutic targeting[J].Cells,2020,9(2):383.DOI:10.3390/cells9020383.

[28] Verkhratsky A,Butt A,Li B,et al.Astrocytes in human central nervous system diseases:a frontier for new therapies[J].Signal Transduct Target Ther,2023,8(1):396.DOI:10.1038/s41392-023-01628-9.

[29] Vainchtein ID,Molofsky AV.Astrocytes and microglia:in sickness and in health[J].Trends Neurosci,2020,43(3):144-154.DOI:10.1016/j.tins.2020.01.003.

[30] Yang K,Lv Z,Zhao W,et al.The potential of natural products to inhibit abnormal aggregation of α-synuclein in the treatment of Parkinson's disease[J].Front Pharmacol,2024,15:1468850.DOI:10.3389/fphar.2024.1

[31] Fu L,Jiang G,Weng H,et al.Cerebrovascular miRNAs correlate with the clearance of Aβ through perivascular route in younger 3xTg-AD mice[J].Brain Pathol,2020,30(1):92-105.DOI:10.1111/bpa.12759.

[32] Yue Q,Leng X,Xie N,et al.Endothelial dysfunctions in blood-brain barrier breakdown in Alzheimer's disease:from mechanisms to potential therapies[J].CNS Neurosci Ther,2024,30(11):e70079.DOI:10.1111/cns.70079.

[33] Huang Y,Happonen KE,Burrola PG,et al.Microglia use TAM receptors to detect and engulf amyloid β plaques[J].Nat Immunol,2021,22(5):586-594.DOI:10.1038/s41590-021-00913-5.

[34] Hu J,Chen Q,Zhu H,et al.Microglial Piezo1 senses Aβ fibril stiffness to restrict Alzheimer's disease[J].Neuron,2023,111(1):15-29.e8.DOI:10.1016/j.neuron.2022.10.021.

[35] Deng Q,Wu C,Parker E,et al.Microglia and astrocytes in Alzheimer's disease:significance and summary of recent advances[J].Aging Dis,2024,15(4):1537-1564.DOI:10.14336/ad.2023.0907.

[36] Heinrich MA,Huynh NT,Heinrich L,et al.Understanding glioblastoma stromal barriers against NK cell attack using tri-culture 3D spheroid model[J].Heliyon,2024,10(3):e24808.DOI:10.1016/j.heliyon.2024.e24808.

基本信息:

中图分类号:R749.16

引用信息:

[1]张帅强,吴丽娥,郭孖,等.神经胶质细胞介导的神经炎症与阿尔茨海默病发病机制的研究进展[J].中华老年心脑血管病杂志,2025,27(08):1129-1132.

基金信息:

内蒙古自治区自然科学基金项目(2024LHMS08004); 内蒙古医学科学院公立医院科研联合基金科技项目(2023GLLH0191;2024GLLH0565)

发布时间:

2025-08-07

出版时间:

2025-08-07

检 索 高级检索

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文